Tvardi Therapeutics, Inc. Common Stock logo

Tvardi Therapeutics, Inc. Common Stock

TVRDNASDAQ

Tvardi Therapeutics, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO Imran Alibhai, with a market cap of $29.6M.

Market Cap$29.6M
CEOImran Alibhai
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Next EarningsMay 12, 2026 · In 2 weeksBefore Market Open · Q1 2026

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric
TVR

Tvardi Therapeutics, Inc. Common Stock FAQ

Common questions about Tvardi Therapeutics, Inc. Common Stock

Tvardi Therapeutics, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 12, 2026 before market open.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.